SE9803760D0 - Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel - Google Patents

Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel

Info

Publication number
SE9803760D0
SE9803760D0 SE9803760A SE9803760A SE9803760D0 SE 9803760 D0 SE9803760 D0 SE 9803760D0 SE 9803760 A SE9803760 A SE 9803760A SE 9803760 A SE9803760 A SE 9803760A SE 9803760 D0 SE9803760 D0 SE 9803760D0
Authority
SE
Sweden
Prior art keywords
cei
restless legs
legs syndrome
sleep
diagnose
Prior art date
Application number
SE9803760A
Other languages
English (en)
Swedish (sv)
Inventor
Jan Edner
Holger Kraiczi
Original Assignee
Jan Hedner
Holger Kraiczi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Hedner, Holger Kraiczi filed Critical Jan Hedner
Priority to SE9803760A priority Critical patent/SE9803760D0/xx
Publication of SE9803760D0 publication Critical patent/SE9803760D0/xx
Priority to PCT/SE1999/001979 priority patent/WO2000025821A1/en
Priority to AT99957453T priority patent/ATE302025T1/de
Priority to EP99957453A priority patent/EP1154795B1/en
Priority to DK99957453T priority patent/DK1154795T3/da
Priority to ES99957453T priority patent/ES2251242T3/es
Priority to DE69926804T priority patent/DE69926804T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Advance Control (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9803760A 1998-11-04 1998-11-04 Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel SE9803760D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9803760A SE9803760D0 (sv) 1998-11-04 1998-11-04 Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
PCT/SE1999/001979 WO2000025821A1 (en) 1998-11-04 1999-11-03 Method of treating and diagnosing restless legs syndrome and corresponding means
AT99957453T ATE302025T1 (de) 1998-11-04 1999-11-03 Vorrichtungen zur behandlung und diagnose des restless leg syndroms
EP99957453A EP1154795B1 (en) 1998-11-04 1999-11-03 Means for treating and diagnosing restless legs syndrome
DK99957453T DK1154795T3 (da) 1998-11-04 1999-11-03 Middel til behandling af diagnosticering af restless legs syndrom
ES99957453T ES2251242T3 (es) 1998-11-04 1999-11-03 Medio para tratar y diagnosticar el sindrome de piernas inquietas.
DE69926804T DE69926804T2 (de) 1998-11-04 1999-11-03 Vorrichtungen zur behandlung und diagnose des restless leg syndroms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803760A SE9803760D0 (sv) 1998-11-04 1998-11-04 Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel

Publications (1)

Publication Number Publication Date
SE9803760D0 true SE9803760D0 (sv) 1998-11-04

Family

ID=20413169

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803760A SE9803760D0 (sv) 1998-11-04 1998-11-04 Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel

Country Status (7)

Country Link
EP (1) EP1154795B1 (xx)
AT (1) ATE302025T1 (xx)
DE (1) DE69926804T2 (xx)
DK (1) DK1154795T3 (xx)
ES (1) ES2251242T3 (xx)
SE (1) SE9803760D0 (xx)
WO (1) WO2000025821A1 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
PT1685839E (pt) 1997-12-22 2013-07-08 Euro Celtique Sa Forma de dosagem farmacêutica por via oral compreendendo uma combinação de um agonista opióide e de um antagonista opióide
DE19938823A1 (de) * 1999-08-19 2001-02-22 Boehringer Ingelheim Pharma Medikamentöse Behandlung des Restless Leg Syndroms
CN100398154C (zh) * 2001-03-30 2008-07-02 东丽株式会社 精神神经疾病治疗药
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
DE20308437U1 (de) 2002-04-05 2003-11-13 Euroceltique S.A., Luxemburg/Luxembourg Matrix zur verzögerten, gleichbleibenden und unabhängigen Freisetzung von Wirkstoffen
US6960571B2 (en) * 2003-03-14 2005-11-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
WO2005016327A2 (en) * 2003-08-13 2005-02-24 Janssen Pharmaceutica, N.V. Treatment of sleep disorders with cholinesterase inhibitors
WO2005042475A2 (en) 2003-10-21 2005-05-12 Sention, Inc. Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
US20050267176A1 (en) * 2004-02-18 2005-12-01 Sepracor Inc. Dopamine-agonist combination therapy for improving sleep quality
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1891946A1 (en) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Transmucosal administration of 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone
JP2010518010A (ja) 2007-02-02 2010-05-27 コルシド・ファーマシューティカルズ・インコーポレイテッド コリンエステラーゼを阻害する化合物
US20090048229A1 (en) * 2007-07-18 2009-02-19 Rupniak Nadia M J Methods for promoting wakefulness
PT2405915T (pt) 2009-03-10 2019-01-29 Euro Celtique Sa Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona
EP2251010A1 (en) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions
CA2790164A1 (en) 2010-02-17 2011-08-25 Sun Pharma Advanced Research Company Ltd. Method of treating a disease condition susceptible to baclofen therapy
NZ716267A (en) 2013-07-23 2017-05-26 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO274596A0 (en) * 1996-10-04 1996-10-31 Armstrong, Stuart Maxwell Method for the treatment of neurological or neuropsychiatric disorders
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms

Also Published As

Publication number Publication date
DE69926804T2 (de) 2006-06-22
DK1154795T3 (da) 2006-01-02
WO2000025821A1 (en) 2000-05-11
EP1154795A1 (en) 2001-11-21
ATE302025T1 (de) 2005-09-15
ES2251242T3 (es) 2006-04-16
DE69926804D1 (de) 2005-09-22
EP1154795B1 (en) 2005-08-17

Similar Documents

Publication Publication Date Title
SE9803760D0 (sv) Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
PL356252A1 (en) Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
ES2166111T3 (es) Uso de tiagabina para el tratamiento de trastornos del sueño.
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
BR0111980A (pt) Amina substituìda, composto protegido, métodos para tratar um paciente que tenha ou para prevenir que um paciente contraia uma doença ou condição, para inibir a atividade da beta-secretase, para inibir a clivagem da proteìna precursora de amilóide (app), para inibir a produção do peptìdeo beta amilóide (a beta) em uma célula, para inibir a produção de placa beta0amilóide em um animal, e para tratar ou prevenir uma doença compreendendo depósitos de beta-amilóide no cérebro, composição método para produzir um complexo de beta-secretase, conjunto, e, uso de amina substituìda
BR0211119A (pt) Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
EA199800626A1 (ru) Применение агониста ppar-гамма для лечения синдрома х
NO20042964L (no) Spiroazasykliske forbindelser som monoaminreseptormodulatorer
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
EA200101089A1 (ru) Новый способ лечения
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
NO20024646D0 (no) Kombinasjonsterapier med vaskul¶r-skadende aktivitet
DK1296972T3 (da) Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
SE0201713D0 (sv) New methods and use III
DK0946162T3 (da) Anvendelse af p-aminophenol-derivater til fremstilling af farmaceutiske præparater, som er nyttige til behandlingen af neurodegenerative sygdomme
DE60129829D1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
MXPA02012730A (es) Uso de acido pamoico o uno de sus derivados o uno de sus analogos para la preparacion de un medicamento para el tratamiento de enfermedades caracterizadas por depositos de agregados de amiloide.
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
SE0004101D0 (sv) New use
FR2690847B1 (fr) Compositions a activite agoniste des recepteurs analogues a 5ht1 selective.
SE9902387D0 (sv) New pharmaceutically active compounds
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea